Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Immunology
IF: 1.352 5-Year IF: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Print: 1040-8401
ISSN Online: 2162-6472

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v15.i3-4.70
pages 317-348

The Mucosal Adjuvant Activities of ADP-Ribosylating Bacterial Enterotoxins

Denis P. Snider
Department of Pathology, HSC-3N26H, McMaster University, 1200 Main St. W., Hamilton, Ontario, Canada L8N 3Z5


The bacterial enterotoxins, cholera toxin and the heat labile toxin of E. coli, are well known adjuvants for mucosal immune response. Their common A chain mediates the toxigenic mechanism by causing ADP ribosylation of G proteins and subsequent elevation of cAMP in target cells. A large IgA and IgG antibody response to admixed protein antigen (Ag) is the hallmark of these adjuvants and is clearly associated with the A chain activity. Expansion of Ag-specific B and T cells, alteration of T cell cytokine production, and changes in regulatory T cells have been reported as adjuvant mechanisms. The B chain derivatives of these toxins can also weakly enhance immune response, especially if covalently associated with Ag and used for nasophyrangeal immunization. Importantly, these toxins or their B chain derivatives can alter the normal immune regulation that produces oral tolerance. This indicates that they modulate mechanisms operative between the mucosal and systemic immune systems. There are some discrepancies between in vitro models of CT or LT activity and in vivo manifestations of their adjuvant activities. Interpretation of current data regarding in vivo mechanism is hampered by an incomplete understanding of how mucosal B and T cells can interact with systemic lymphoid tissue and vice versa. More important, there is no clear understanding of the early effects of the toxins on the local (and draining) mucosal lymphoid tissues. This is especially true in the critical areas of antigen presentation, T and B cell activation, and cytokine production.

Articles with similar content:

The Mucosal Adjuvant Activities of ADP-Ribosylating Bacterial Enterotoxins
Critical Reviews™ in Immunology, Vol.37, 2017, issue 2-6
Denis P. Snider
Role of the Glucocorticoid-Induced TNFR-Related Protein (GITR)-GITR Ligand Pathway in Innate and Adaptive Immunity
Critical Reviews™ in Immunology, Vol.30, 2010, issue 6
Miyuki Azuma
Expression of Inhibitory Receptors for MHC Class I Molecules on T Cells
Critical Reviews™ in Immunology, Vol.20, 2000, issue 6
Bertrand Huard
Mucosal Immunization: A Review of Strategies and Challenges
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.31, 2014, issue 4
Mohan N. Rathi, Hinal Patel, Chetan Yewale, Ambikanandan Misra
Heterogeneity of Memory Marginal Zone B Cells
Critical Reviews™ in Immunology, Vol.38, 2018, issue 2
Jacobus Hendricks, Nicolaas A. Bos, Frans G.M. Kroese